Consistent with our prior observations11, anti-CD40L treatment at tumor implantation did not impact the number of SIY-specific T cells, but significantly decreased the proportion of antigen-specific T cells that express CD103 (Supplementary Fig. S4c). This evidence concerns the gene CD40LG and neoplasm.